| Name | P/E | PEG | Dividend Yield | Operating Margin | ROCE | Return on Assets | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4basebio | -1,180.9 | 0.0 | 0.00% | -1,290.68% | -0.53% | -0.28% | |||||||||||||
| 4D Pharma | 0.0 | 0.0 | 0.00% | -13,502.49% | -2.92% | -1.26% | |||||||||||||
| Abcam | 0.0 | 0.0 | 0.00% | 5.27% | 0.07% | 0.02% | |||||||||||||
| Abzena | 0.0 | 0.0 | 0.00% | -68.06% | -0.65% | -0.26% | |||||||||||||
| Agronomics Limited | -5.6 | 0.0 | 0.00% | n/a | -0.08% | -0.07% | |||||||||||||
| Allergy Therapeutics | -6.6 | 0.0 | 0.00% | -63.87% | -1.07% | -0.62% | |||||||||||||
| Alliance Pharma | 15.0 | -3.1 | 0.00% | -4.53% | -0.08% | -0.03% | |||||||||||||
| Animalcare Group | 25.5 | 27.7 | 1.79% | 9.50% | 0.08% | 0.03% | |||||||||||||
| Anpario | 15.8 | 0.2 | 2.51% | 12.81% | 0.19% | 0.09% | |||||||||||||
| Aptamer Group | -0.5 | 0.0 | 0.00% | -358.60% | -1.94% | -1.07% | |||||||||||||
| Aqua Bounty Technologies Inc. (Reg S) | 0.0 | 0.0 | 0.00% | n/a | -1.28% | -1.08% | |||||||||||||
| Arecor Therapeutics | -140.3 | 0.0 | 0.00% | -211.70% | -1.93% | -1.17% | |||||||||||||
| Argent Biopharma Limited NPV (DI) | 0.0 | 0.0 | 0.00% | -1,874.30% | -4.36% | -1.63% | |||||||||||||
| AstraZeneca | 17.6 | 1.3 | 2.15% | 18.50% | 0.58% | 0.07% | |||||||||||||
| Avacta Group | -4.2 | 0.0 | 0.00% | -96.83% | 16.32% | -0.34% | |||||||||||||
| Benchmark Holdings | -4.0 | 0.0 | 0.00% | -39.28% | -0.20% | -0.12% | |||||||||||||
| Beximco Pharmaceuticals Ltd. GDR (Reg S) | 1,207.9 | 55.1 | 0.02% | 21.99% | 0.11% | 0.06% | |||||||||||||
| Biodexa Pharmaceuticals | n/a | n/a | n/a | n/a | n/a | n/a | |||||||||||||
| Biofrontera AG (DI) | 0.0 | 0.0 | 0.00% | -279.67% | -1.02% | -0.77% | |||||||||||||
| Bioventix | 18.9 | -5.5 | 5.30% | 77.79% | 0.76% | 0.59% | |||||||||||||
| BiVictriX Therapeutics | 0.0 | 0.0 | 0.00% | n/a | -0.83% | -0.59% | |||||||||||||
| BTG | 0.0 | 0.0 | 0.00% | 14.00% | 0.23% | 0.07% | |||||||||||||
| C4X Discovery Holdings | 0.0 | 0.0 | 0.00% | -784.44% | -2.35% | -1.26% | |||||||||||||
| Chill Brands Group | -1.2 | 0.0 | 0.00% | -496.82% | -0.90% | -0.70% | |||||||||||||
| Cizzle Biotechnology Holdings | -3.9 | 0.0 | 0.00% | n/a | n/a | -4.40% | |||||||||||||
| Cyprotex | 0.0 | 0.0 | 0.00% | 12.68% | 0.15% | -0.42% | |||||||||||||
| Dechra Pharmaceuticals | 0.0 | 0.0 | 0.00% | 0.83% | 0.01% | -0.02% | |||||||||||||
| Deepverge Plc | 0.0 | 0.0 | 0.00% | -36.34% | -0.32% | -0.09% | |||||||||||||
| Destiny Pharma | 0.0 | 0.0 | 0.00% | n/a | -0.98% | -0.57% | |||||||||||||
| Diurnal Group | 0.0 | 0.0 | 0.00% | -404.68% | -0.89% | -0.62% | |||||||||||||
| e-Therapeutics | 0.0 | 0.0 | 0.00% | -2,155.58% | -0.31% | -0.24% | |||||||||||||
| EastPharma Ltd GDR (Reg S) | 0.0 | 0.0 | 0.00% | 12.96% | 0.09% | 0.02% | |||||||||||||
| ECO Animal Health Group | 39.4 | 9.8 | 0.00% | 3.95% | 0.07% | 0.01% | |||||||||||||
| Eden Research | -11.0 | 0.0 | 0.00% | -50.81% | -0.42% | -0.12% | |||||||||||||
| Ergomed | 0.0 | 0.0 | 0.00% | 12.99% | 0.55% | 0.12% | |||||||||||||
| Faron Pharmaceuticals Oy (DI) | -10.7 | 0.0 | 0.00% | n/a | -15.08% | -2.07% | |||||||||||||
| Futura Medical | 21.3 | 0.0 | 0.00% | 8.93% | -4.85% | 0.10% | |||||||||||||
| Genflow Biosciences | -1.8 | 0.0 | 0.00% | n/a | n/a | -4.11% | |||||||||||||
| Genus | 30.8 | -1.4 | 1.59% | 0.96% | 0.03% | 0.01% | |||||||||||||
| GSK | 9.5 | 3.5 | 4.05% | 12.82% | 0.47% | 0.04% | |||||||||||||
| Gunsynd | -0.7 | 0.0 | 0.00% | 413.23% | -0.54% | -0.50% | |||||||||||||
| GW Pharmaceuticals | 0.0 | 0.0 | 0.00% | -200.53% | -0.24% | -0.15% | |||||||||||||
| Haleon | 26.2 | 0.7 | 1.59% | 19.64% | 0.62% | 0.04% | |||||||||||||
| Hemogenyx Pharmaceuticals | -1.0 | 0.0 | 0.00% | n/a | -1.79% | -1.33% | |||||||||||||
| Hikma Pharmaceuticals | 12.9 | 28.7 | 2.78% | 19.57% | 0.24% | 0.07% | |||||||||||||
| Horizon Discovery Group | 0.0 | 0.0 | 0.00% | -17.27% | -0.21% | -0.03% | |||||||||||||
| HUTCHMED (China) Limited | 69.7 | -1.0 | 0.00% | 6.58% | -0.04% | 0.03% | |||||||||||||
| Hvivo | 0.0 | 0.0 | 0.00% | -164.40% | -1.23% | -0.60% | |||||||||||||
| Immupharma | -4.4 | 0.0 | 0.00% | n/a | 4.84% | -2.54% | |||||||||||||
| Indivior | -35.3 | 0.0 | 0.00% | -1.94% | -0.42% | -0.03% | |||||||||||||
| Ixico | -2.7 | 0.0 | 0.00% | -37.36% | -0.63% | -0.18% | |||||||||||||
| LungLife AI, Inc (DI) | -0.3 | 0.0 | 0.00% | -12,243.48% | -1.61% | -0.57% | |||||||||||||
| Maxcyte Inc (DI/REG S) | 0.0 | 0.0 | 0.00% | -132.54% | -0.23% | -0.17% | |||||||||||||
| Mereo Biopharma Group | 0.0 | 0.0 | 0.00% | n/a | -1.28% | -0.40% | |||||||||||||
| Motif Bio | 0.0 | 0.0 | 0.00% | n/a | -1.59% | -1.23% | |||||||||||||
| N4 Pharma | -0.9 | 0.0 | 0.00% | -71,249.99% | n/a | -1.00% | |||||||||||||
| Nuformix | -0.2 | 0.0 | 0.00% | n/a | n/a | -3.75% | |||||||||||||
| Okyo Pharma Limited NPV | 0.0 | 0.0 | 0.00% | n/a | n/a | -1.21% | |||||||||||||
| Ondine Biomedical Inc. NPV (CDI) | -1.6 | 0.0 | 0.00% | -1,230.67% | -5.58% | -2.51% | |||||||||||||
| OptiBiotix Health | -6.5 | 0.0 | 0.00% | -263.20% | -0.26% | -0.22% | |||||||||||||
| Ovoca Bio (CDI) | -0.2 | 0.0 | 0.00% | n/a | -2.04% | -1.36% | |||||||||||||
| Oxford Biomedica | -7.8 | 0.0 | 0.00% | -30.57% | -0.27% | -0.19% | |||||||||||||
| Oxford Cannabinoid Technologies Holdings | 0.0 | 0.0 | 0.00% | n/a | -1.80% | -1.32% | |||||||||||||
| Oxford Nanopore Technologies | -7.7 | 0.0 | 0.00% | -83.16% | -0.26% | -0.20% | |||||||||||||
| Pfizer Inc. | 0.0 | 0.0 | 0.00% | 12.61% | n/a | n/a | |||||||||||||
| OJSC Pharmstandard GDR (Reg S) | n/a | n/a | n/a | n/a | n/a | n/a | |||||||||||||
| Plethora Solutions Holdings | 0.0 | 0.0 | 0.00% | -419.63% | -3.55% | -2.76% | |||||||||||||
| Poolbeg Pharma | -2.8 | 0.0 | 0.00% | n/a | 0.02% | -0.57% | |||||||||||||
| Proteome Sciences | -2.9 | 0.0 | 0.00% | -48.15% | -0.56% | -0.37% | |||||||||||||
| PureTech Health | 8.7 | 0.0 | 0.00% | -2,818.87% | 0.04% | 0.09% | |||||||||||||
| Quantum Pharma | 0.0 | 0.0 | 0.00% | -11.10% | -1.17% | -0.25% | |||||||||||||
| Redx Pharma | 0.0 | 0.0 | 0.00% | -804.85% | -1.56% | -1.29% | |||||||||||||
| ReNeuron Group | 0.0 | 0.0 | 0.00% | -1,342.45% | -1.34% | -0.56% | |||||||||||||
| Sareum Holdings | -3.4 | 0.0 | 0.00% | n/a | -2.19% | -1.24% | |||||||||||||
| Scancell Holdings | -14.7 | 0.0 | 0.00% | n/a | -0.51% | -0.25% | |||||||||||||
| Shield Therapeutics | -0.8 | 0.0 | 0.00% | -71.08% | -3.32% | -0.47% | |||||||||||||
| Shire Plc | 0.0 | 0.0 | 0.00% | 16.19% | 0.32% | 0.06% | |||||||||||||
| Silence Therapeutics | 0.0 | 0.0 | 0.00% | -654.20% | -28.50% | -0.38% | |||||||||||||
| Sinclair Pharma | 0.0 | 0.0 | 0.00% | -4.77% | 0.11% | 0.00% | |||||||||||||
| SkinBioTherapeutics | -12.2 | 0.0 | 0.00% | -240.36% | -5.67% | -0.55% | |||||||||||||
| Skyepharma | 0.0 | 0.0 | 0.00% | 32.85% | 0.59% | 0.25% | |||||||||||||
| Solvonis Therapeutics | -1.1 | 0.0 | 0.00% | n/a | -1.39% | -0.50% | |||||||||||||
| Source BioScience | 0.0 | 0.0 | 0.00% | 8.94% | 0.17% | 0.03% | |||||||||||||
| Summit Therapeutics | 0.0 | 0.0 | 0.00% | 6.21% | 0.08% | 0.13% | |||||||||||||
| Synairgen | -0.3 | 0.0 | 0.00% | n/a | -0.82% | -0.59% | |||||||||||||
| Taihua | 0.0 | 0.0 | 0.00% | -88.11% | n/a | -0.22% | |||||||||||||
| Theracryf | -0.2 | 0.0 | 0.00% | -892.50% | -1.55% | -1.03% | |||||||||||||
| Tiziana Life Sciences | 0.0 | 0.0 | 0.00% | n/a | -0.47% | -0.39% | |||||||||||||
| Valirx | -0.3 | 0.0 | 0.00% | -22,990.00% | -3.80% | -0.68% | |||||||||||||
| Vectura Group | 0.0 | 0.0 | 0.00% | 69.67% | 0.47% | 0.18% | |||||||||||||
| Verici DX | -0.2 | 0.0 | 0.00% | -875.32% | -5.44% | -1.17% | |||||||||||||
| Vernalis plc | 0.0 | 0.0 | 0.00% | -127.03% | -0.43% | -0.23% | |||||||||||||
| Verona Pharma | 0.0 | 0.0 | 0.00% | n/a | -1.30% | -0.71% | |||||||||||||
| Verseon Corporation (DI/REG S) | 0.0 | 0.0 | 0.00% | n/a | -0.42% | -0.38% | |||||||||||||
| Verseon Corporation (Reg S Cat 3) | 0.0 | 0.0 | 0.00% | n/a | -0.42% | -0.38% | |||||||||||||
| Yourgene Health | 0.0 | 0.0 | 0.00% | -6.76% | -0.08% | -0.03% | |||||||||||||